Similar Search Results

The impact of pharmaceutical innovation on cancer mortality in Belgium : 2004-2012

Lichtenberg, Frank R. - In: Forum for health economics & policy : an evolving … 20 (2017) 1, pp. 1-28

Persistent link: https://www.econbiz.de/10011701670

The impact of new drug launches on longevity growth in nine Middle Eastern and African countries, 2007-2015

Lichtenberg, Frank R. - In: Review of Middle East economics and finance 14 (2018) 3, pp. 1-15

Persistent link: https://www.econbiz.de/10011964261

The impact of biopharmaceutical innovation on disability, social security recipiency, and use of medical care of U.S. community residents, 1998-2015

Lichtenberg, Frank R. - In: Forum for health economics & policy : an evolving … 24 (2021) 1, pp. 35-74

Persistent link: https://www.econbiz.de/10013556762

Pharmaceutical Innovation and U.S. Cancer Survival, 1992-2003: Evidence from Linked SEER-MEDSTAT Data

Lichtenberg, Frank R. - In: Forum for Health Economics & Policy 10 (2008) 1

This study examines the impact of pharmaceutical innovation and other factors on the survival of U.S. cancer patients … other types of medical innovation, i.e. other pharmaceutical innovation, and innovation in surgical procedures, diagnostic … of rates of innovation in chemotherapy and other treatment and diagnostic procedures are constructed from the MEDSTAT …

Persistent link: https://www.econbiz.de/10014591965

Measuring technological novelty with patent-based indicators

Verhoeven, Dennis; Bakker, Jurriën; Veugelers, Reinhilde - In: Research policy : policy, management and economic … 45 (2016) 3, pp. 707-723

Persistent link: https://www.econbiz.de/10011598211

The impact of new drug launches on life-years lost in 2015 from 19 types of cancer in 36 countries

Lichtenberg, Frank R. - In: Journal of demographic economics : JODE 84 (2018) 3, pp. 309-354

Persistent link: https://www.econbiz.de/10012007105

The impact of new drug launches on hospitalization in 2015 for 67 medical conditions in 15 OECD countries : a two-way fixed-effects analysis

Lichtenberg, Frank R. - In: Forum for health economics & policy : an evolving … 21 (2018) 2, pp. 1-20

Persistent link: https://www.econbiz.de/10012022614

In Search of Complementarity in Innovation Strategy: Internal R& D and External Knowledge Acquisition

Cassiman, Bruno; Veugelers, Reinhilde - In: Management Science 52 (2006) 1, pp. 68-82

external knowledge acquisition are complementary innovation activities, but that the degree of complementarity is sensitive to … existence of complementarity. We use our empirical methodology to analyze complementarity between innovation activities …: internal research and development (R& D) and external knowledge acquisition. Our results suggest that internal R& D and …

Persistent link: https://www.econbiz.de/10009204237

Chapter 15 Economics of defense R&D

Lichtenberg, Frank R. - In: Handbook of defense economics : volume 1, (pp. 431-457). 1995

This chapter examines a number of aspects of defense R&D, including: mechanisms — design competitions, and independent R&D subsidies — used by the US government to encourage firms to invest their own funds in defense R&D; theory and evidence concerning both the private and social benefits of,...

Persistent link: https://www.econbiz.de/10014024416

Complementarity in the innovation strategy : internal R&D, external technology acquisition and cooperation

Cassiman, Bruno - 2002

Persistent link: https://www.econbiz.de/10013423874